Immunogenic Cell Death Role in Urothelial Cancer Therapy

Purpose: Bladder cancer is the 13th most common cause of cancer death with the highest lifetime cost for treatment of all cancers. This scoping review clarifies the available evidence on the role of a novel therapeutic approach called immunogenic cell death (ICD) in urothelial cancer of the bladder....

Descripción completa

Detalles Bibliográficos
Autores principales: Yadollahvandmiandoab, Reza, Jalalizadeh, Mehrsa, Buosi, Keini, Garcia-Perdomo, Herney Andrés, Reis, Leonardo Oliveira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498148/
https://www.ncbi.nlm.nih.gov/pubmed/36135095
http://dx.doi.org/10.3390/curroncol29090526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498148/
https://www.ncbi.nlm.nih.gov/pubmed/36135095
http://dx.doi.org/10.3390/curroncol29090526

Ejemplares similares